Thermo Fisher's updated 2025 guidance shows a $1 EPS, or 4.2% hit from tariffs and government spending cuts. Thermo can mitigate the tariff issues by next year, as its scale gives it options to ...

Life sciences company Thermo Fisher (NYSE:TMO) will be reporting earnings tomorrow before the bell. Here’s what to expect. Thermo Fisher beat analysts’ revenue expectations by 1% last quarter ...

Thermo Fisher Scientific received site plan approval from the Pease Development Authority to build a new aircraft hangar and office at the Pease International Tradeport. The project includes a two ...

Forbes contributors publish independent expert analyses and insights. Thermo Fisher Scientific provides products and services that support the life sciences industry, including large ...

Shares of Solventum rose Tuesday after the company agreed to sell its filtration and purification business to medical device maker Thermo Fisher Scientific for $4.1 billion. Solventum Chief ...

Thermo Fisher Scientific is expanding its life sciences portfolio by acquiring a division of Solventum that provides technologies and products used in the manufacturing of biologic drugs.

WALTHAM, Mass., February 25, 2025--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO) ("Thermo Fisher"), the world leader in serving science, today announced that the company has entered ...

Thermo Fisher said it is paying about $4.1 billion in cash for the business. The Journal reported in October that Solventum, the healthcare company spun off from 3M last year, had retained bankers ...

Thermo Fisher Scientific has received 510(k ... support to clinical communities as they look for reliable and efficient testing solutions,” said Rosy Lee, President, Genetic Sciences. Workflow ...

For the second time in less than three months, Thermo Fisher Scientific has announced layoffs. The Waltham life sciences firm, the most valuable publicly traded company in Massachusetts ...

VCG / Getty Images Thermo Fisher Scientific shares jumped Thursday after the medical device maker reported better-than-expected fourth-quarter results. Sales and profit increased year-over-year ...

The company has introduced to market its Accelerator™ Drug Development, which Thermo Fisher is marketing as “360°” CDMO and CRO drug development solutions, following a formal announcement ...